跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Etelcalcetide Hydrochloride Injection
Approved
化学药品
Etelcalcetide Hydrochloride Injection
AMGEN EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
May 6, 2023
Approval ID
1yQCPe5mhAM
Company
AMGEN EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
1yQCPe5mhAM
Approval Number
国药准字HJ20230046
Generic Name
盐酸依特卡肽注射液
Generic Name En
Etelcalcetide Hydrochloride Injection
Trade Name
旁必福
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.5ml:2.5mg(按C₃₈H₇₃N₂₁O₁₀S₂计)
Reg Date
2023-05-06
Expired Date
2028-05-05
Company Name
AMGEN EUROPE B.V.
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/amgen-europe-b-v
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 6, 2023
Approval ID
1yQCPe5mhAM
Type
化学药品
Back to NMPA Approvals
旁必福 - NMPA Drug Approval Details